To determine if RYBP affects the chemosensitivity of HCC cells, we first tested whether RYBP OE would sensitize HCC cells to treatment with cisplatin or 5-FU, which have been the most effective agents used as systemic chemotherapy for HCC [18]. The gene discussed is RYBP; the disease is hepatocellular carcinoma.